Cargando…
Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations
Idiopathic pulmonary fibrosis (IPF) is a parenchymal lung disease characterized by progressive interstitial fibrosis. The clinical course of IPF can be unpredictable and may be punctuated by acute exacerbations. Although much progress is being made in unraveling the mechanisms underlying IPF, effect...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013866/ https://www.ncbi.nlm.nih.gov/pubmed/27625576 http://dx.doi.org/10.4137/CCRPM.S39897 |
_version_ | 1782452233125756928 |
---|---|
author | Nakamura, Yutaro Suda, Takafumi |
author_facet | Nakamura, Yutaro Suda, Takafumi |
author_sort | Nakamura, Yutaro |
collection | PubMed |
description | Idiopathic pulmonary fibrosis (IPF) is a parenchymal lung disease characterized by progressive interstitial fibrosis. The clinical course of IPF can be unpredictable and may be punctuated by acute exacerbations. Although much progress is being made in unraveling the mechanisms underlying IPF, effective therapy for improving survival remains elusive. Longitudinal disease profiling, especially in terms of clinical manifestations in a large cohort of patients, should lead to proper management of the patients and development of new treatments for IPF. Appropriate multidisciplinary assessment in ongoing registries is required to achieve this. This review summarizes the current status of the diagnosis and clinical manifestations of IPF. |
format | Online Article Text |
id | pubmed-5013866 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Libertas Academica |
record_format | MEDLINE/PubMed |
spelling | pubmed-50138662016-09-13 Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations Nakamura, Yutaro Suda, Takafumi Clin Med Insights Circ Respir Pulm Med Review Idiopathic pulmonary fibrosis (IPF) is a parenchymal lung disease characterized by progressive interstitial fibrosis. The clinical course of IPF can be unpredictable and may be punctuated by acute exacerbations. Although much progress is being made in unraveling the mechanisms underlying IPF, effective therapy for improving survival remains elusive. Longitudinal disease profiling, especially in terms of clinical manifestations in a large cohort of patients, should lead to proper management of the patients and development of new treatments for IPF. Appropriate multidisciplinary assessment in ongoing registries is required to achieve this. This review summarizes the current status of the diagnosis and clinical manifestations of IPF. Libertas Academica 2016-09-06 /pmc/articles/PMC5013866/ /pubmed/27625576 http://dx.doi.org/10.4137/CCRPM.S39897 Text en © 2015 the author(s), publisher and licensee Libertas Academica Ltd. This is an open-access article distributed under the terms of the Creative Commons CC-BY-NC 3.0 License. |
spellingShingle | Review Nakamura, Yutaro Suda, Takafumi Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations |
title | Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations |
title_full | Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations |
title_fullStr | Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations |
title_full_unstemmed | Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations |
title_short | Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations |
title_sort | idiopathic pulmonary fibrosis: diagnosis and clinical manifestations |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013866/ https://www.ncbi.nlm.nih.gov/pubmed/27625576 http://dx.doi.org/10.4137/CCRPM.S39897 |
work_keys_str_mv | AT nakamurayutaro idiopathicpulmonaryfibrosisdiagnosisandclinicalmanifestations AT sudatakafumi idiopathicpulmonaryfibrosisdiagnosisandclinicalmanifestations |